[1] |
刘璇. 2型糖尿病合并甲状腺疾病的患病情况和影响因素分析[D]. 兰州: 兰州大学, 2018.
|
[2] |
SHIN D J, WANG L. Bile acid-activated receptors:a review on FXR and other nuclear receptors[J]. Handb Exp Pharmacol, 2019, 256:51-72.
|
[3] |
FIORUCCI S, DISTRUTTI E, CARINO A, et al. Bile acids and their receptors in metabolic disorders[J]. Prog Lipid Res, 2021, 82:101094.
DOI
URL
|
[4] |
XU Y. Recent progress on bile acid receptor modulators for treatment of metabolic diseases[J]. J Med Chem, 2016, 59(14):6553-6579.
DOI
PMID
|
[5] |
中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 甲状腺功能亢进症基层诊疗指南(2019年)[J]. 中华全科医师杂志, 2019, 18(12):1118-1128.
|
[6] |
倪青. 甲状腺功能亢进症病证结合诊疗指南(2021-01-20)[J]. 世界中医药, 2021, 16(2):193-196.
|
[7] |
张春玉, 曾洪利, 刘颖, 等. 甲状腺结节与代谢综合征及其组分的相关性分析[J]. 中华内分泌代谢杂志, 2012, 28(2):132-135.
|
[8] |
SONG Y, ZHAO M, ZHANG H, et al. Thyroid-stimulating hormone levels are inversely associated with serum total bile acid levels:a cross-sectional study[J]. Endocr Pract, 2016, 22(4):420-426.
DOI
URL
|
[9] |
符静, 刘佳, 王广. 胆汁酸代谢产物与Graves病患者甲状腺功能的相关性探讨[J]. 解放军医学院学报, 2021, 42(8):802-807.
|
[10] |
毕叶. 甲状腺功能异常对人血清胆汁酸谱的影响[D]. 济南: 山东大学, 2012.
|
[11] |
CHIANG J Y L, FERRELL J M. Discovery of farnesoid X receptor and its role in bile acid metabolism[J]. Mol Cell Endocrinol, 2022, 548:111618.
DOI
URL
|
[12] |
JIA W, XIE G, JIA W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis[J]. Nat Rev Gastroenterol Hepatol, 2018, 15(2):111-128.
DOI
PMID
|
[13] |
JIANG L, ZHANG H, XIAO D, et al. Farnesoid X receptor(FXR):structures and ligands[J]. Comput Struct Biotechnol J, 2021, 19:2148-2159.
DOI
URL
|
[14] |
CHIANG J Y L, FERRELL J M. Up to date on cholesterol 7 alpha-hydroxylase(CYP7A1) in bile acid synthesis[J]. Liver Res, 2020, 4(2):47-63.
DOI
URL
|
[15] |
LANGE T, BUDDE K, HOMUTH G, et al. Comprehensive metabolic profiling reveals a lipid-rich fingerprint of free thyroxine far beyond classic parameters[J]. J Clin Endocrinol Metab, 2018, 103(5):2050-2060.
DOI
PMID
|
[16] |
YANG F, XU W, WU L, et al. NTCP deficiency affects the levels of circulating bile acids and induces osteoporosis[J]. Front Endocrinol(Lausanne), 2022, 13:898750.
|
[17] |
DONKERS J M, ROSCAM ABBING R L P, VAN WEEGHEL M, et al. Inhibition of hepatic bile acid uptake by myrcludex B promotes glucagon-like peptide-1 release and reduces obesity[J]. Cell Mol Gastroenterol Hepatol, 2020, 10(3):451-466.
DOI
PMID
|
[18] |
徐润灏, 邹琛, 张洁, 等. 胆汁酸谱在肺炎和肺癌鉴别诊断中的应用价值[J]. 检验医学, 2021, 36(1):1-7.
|
[19] |
赵元辰, 崔乃强. 胆汁酸与肠道菌群相关性研究进展[J]. 中国中西医结合外科杂志, 2018, 24(5):666-671.
|